This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2025 Oct 2;146(14):1631-1632.

doi: 10.1182/blood.2025030260.

Rebalancing the hemophilia teeter-totter

Thomas C Abshire¹

Affiliations

PMID: 41037302
DOI: 10.1182/blood.2025030260

Editorial

Rebalancing the hemophilia teeter-totter

Thomas C Abshire. Blood. 2025.

. 2025 Oct 2;146(14):1631-1632.

doi: 10.1182/blood.2025030260.

Author

Thomas C Abshire¹

Affiliation

¹ Versiti Blood Research Institute and Medical College of Wisconsin.

PMID: 41037302
DOI: 10.1182/blood.2025030260

No abstract available

PubMed Disclaimer

Comment on

Marstacimab prophylaxis in hemophilia A/B without inhibitors: results from the phase 3 BASIS trial.
Matino D, Palladino A, Taylor CT, Hwang E, Raje S, Nayak S, McDonald R, Acharya SS, Mahlangu J, Jiménez-Yuste V, Choraria N, Yang R, Li CK, Al-Khabori M, Wali Y, Morales Adrián J, Park YS, Zülfikar OB, Teeter J. Matino D, et al. Blood. 2025 Oct 2;146(14):1654-1663. doi: 10.1182/blood.2024027468. Blood. 2025. PMID: 40608864 Clinical Trial.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems